During the past decade, Targeted Medical Pharma conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Targeted Medical Pharma" are "Anemia of Chronic Disease" (1 trials), "Chronic Low Back Pain" (1 trials), "Persian Gulf Syndrome" (1 trials), "Post-traumatic Stress Disorder" (1 trials) and "Sleep Disorder" (1 trials). Many other conditions were trialed in "Targeted Medical Pharma" in a lesser frequency.

Most popular intervention types in "Targeted Medical Pharma" are "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "ESS (medical food/drug)" (1 trials), "Ibuprofen" (1 trials), "Placebo trazodone and placebo Sentra PM" (1 trials), "Sentra PM" (1 trials) and "Sentra PM and Trazodone (CoPack Kit Trazamine)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Targeted Medical Pharma" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Targeted Medical Pharma". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Targeted Medical Pharma, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Targeted Medical Pharma, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".